{
    "medicine_id": "fa0291d603d801de008386812a13736fe71416ac",
    "platform_id": "DB13149",
    "metadata": {
        "name": "Beriplex P n 1000 1200 I E Injection powder for solution",
        "composition": "1200 I E Protein S human",
        "clinical_particulars": {
            "therapeutic_indications": "For use in the emergency reversal of coagulation factor deficiency in patients recieving vitamin K antagonist therapy FDA Label Protein S is administered as part of a cocktail containing several other coagulation factors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Protein S acts as an anticoagulant serves as a negative feedback mechanism in the coagulation cascade A19561",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06605",
                        "description": "Apixaban may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Dabigatran etexilate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Protein S human is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Ursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Glycochenodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Cholic Acid"
                    },
                    {
                        "drugbank-id": "DB02691",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Glycocholic acid"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Deoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Taurocholic acid"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Obeticholic acid"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Chenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08833",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08834",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08857",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Bamet UD2"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB11789",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Hyodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Edoxaban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Protein S human is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Protein S human may increase the anticoagulant activities of Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06206",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Protein S human is combined with Sugammadex"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "Urokinase may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "Vitamin E may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The therapeutic efficacy of Protein S human can be increased when used in combination with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of bleeding can be increased when Ifosfamide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The therapeutic efficacy of Protein S human can be increased when used in combination with Quinine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The therapeutic efficacy of Protein S human can be increased when used in combination with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of bleeding can be increased when Tamoxifen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of bleeding can be increased when Toremifene is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The therapeutic efficacy of Protein S human can be increased when used in combination with Pentoxifylline"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "Pentosan polysulfate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "The therapeutic efficacy of Protein S human can be increased when used in combination with Levocarnitine"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09211",
                        "description": "The risk or severity of adverse effects can be increased when Limaprost is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when SC 236 is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when NS 398 is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04865",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Omacetaxine mepesuccinate"
                    },
                    {
                        "drugbank-id": "DB11133",
                        "description": "Omega 3 fatty acids may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Protein S human is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00048",
                        "description": "The risk or severity of adverse effects can be increased when Protein S human is combined with Collagenase clostridium histolyticum"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "Carbimazole may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "Propylthiouracil may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Methimazole may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "3 5 Diiodotyrosine may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "Potassium Iodide may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "Dibromotyrosine may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Potassium perchlorate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "Methylthiouracil may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "Benzylthiouracil may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB04066",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with p Coumaric acid"
                    },
                    {
                        "drugbank-id": "DB04682",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Octylphenoxy polyethoxyethanol"
                    },
                    {
                        "drugbank-id": "DB05830",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Trestolone"
                    },
                    {
                        "drugbank-id": "DB06266",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Lonidamine"
                    },
                    {
                        "drugbank-id": "DB08867",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ulipristal"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Isosorbide"
                    },
                    {
                        "drugbank-id": "DB11507",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cloprostenol"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Triptolide"
                    },
                    {
                        "drugbank-id": "DB13044",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Gossypol"
                    },
                    {
                        "drugbank-id": "DB13310",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ormeloxifene"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "Desogestrel may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "Levonorgestrel may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00378",
                        "description": "Dydrogesterone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "Norethisterone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "Ethynodiol diacetate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "Norgestimate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "Cyproterone acetate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB06713",
                        "description": "Norelgestromin may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "Gestodene may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "Hydroxyprogesterone caproate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Dienogest may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09124",
                        "description": "Medrogestone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "Norethynodrel may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "Norgestrel may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB11372",
                        "description": "Altrenogest may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "Gestrinone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB11636",
                        "description": "Nomegestrol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "Lynestrenol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13230",
                        "description": "Gestonorone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "Chlormadinone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13533",
                        "description": "Methylestrenolone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "Norgestrienone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13602",
                        "description": "Promegestone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "Quingestanol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "Demegestone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13866",
                        "description": "Etynodiol may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "Nomegestrol acetate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB14570",
                        "description": "Hydroxyprogesterone may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB14678",
                        "description": "Norethindrone enanthate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB14679",
                        "description": "Quingestanol acetate may decrease the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "The risk or severity of bleeding can be increased when Dersalazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09543",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11079",
                        "description": "The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "The risk or severity of bleeding can be increased when Aloxiprin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The risk or severity of bleeding can be increased when Choline salicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of bleeding can be increased when Ticlopidine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of bleeding can be increased when Clopidogrel is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of bleeding can be increased when Tirofiban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Dipyridamole is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Iloprost is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of bleeding can be increased when Cilostazol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of bleeding can be increased when Sevoflurane is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of bleeding can be increased when Resveratrol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Nimesulide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of bleeding can be increased when Tesmilifene is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Defibrotide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Beraprost is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Prasugrel is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Cangrelor is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Triflusal is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Ticagrelor is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of bleeding can be increased when Sarpogrelate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Nitroaspirin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of bleeding can be increased when Ketanserin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Indobufen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of bleeding can be increased when Treprostinil is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB03404",
                        "description": "Hemin may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01481",
                        "description": "1 Testosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01485",
                        "description": "4 Hydroxytestosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01510",
                        "description": "Dehydrochloromethyltestosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01541",
                        "description": "Boldenone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01543",
                        "description": "18 methyl 19 nortestosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01564",
                        "description": "Calusterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01569",
                        "description": "Formebolone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01572",
                        "description": "Methyl 1 testosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB07447",
                        "description": "5beta dihydrotestosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB08619",
                        "description": "Testosterone succinate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB11429",
                        "description": "Mibolerone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Testosterone cypionate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Testosterone enanthate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13947",
                        "description": "Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13951",
                        "description": "Stanolone acetate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB13958",
                        "description": "Trestolone acetate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB14093",
                        "description": "1 2 6 7 3H Testosterone may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB14655",
                        "description": "Drostanolone propionate may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB11051",
                        "description": "The risk or severity of adverse effects can be increased when Protein S human is combined with Azficel T"
                    },
                    {
                        "drugbank-id": "DB09568",
                        "description": "The therapeutic efficacy of Protein S human can be increased when used in combination with Omega 3 carboxylic acids"
                    },
                    {
                        "drugbank-id": "DB00025",
                        "description": "The therapeutic efficacy of Antihemophilic factor human recombinant can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00036",
                        "description": "The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00100",
                        "description": "The therapeutic efficacy of Coagulation Factor IX Recombinant can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The therapeutic efficacy of Calcium can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01783",
                        "description": "The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01942",
                        "description": "The therapeutic efficacy of Formic acid can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB02261",
                        "description": "The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09109",
                        "description": "The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09222",
                        "description": "The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09310",
                        "description": "The therapeutic efficacy of Catridecacog can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11168",
                        "description": "The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11330",
                        "description": "The therapeutic efficacy of Factor IX Complex Human can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11606",
                        "description": "The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11668",
                        "description": "The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12409",
                        "description": "The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12909",
                        "description": "The therapeutic efficacy of Factor XIII human can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13133",
                        "description": "The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13151",
                        "description": "The therapeutic efficacy of Anti inhibitor coagulant complex can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13192",
                        "description": "The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13197",
                        "description": "The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13201",
                        "description": "The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The therapeutic efficacy of Emicizumab can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13999",
                        "description": "The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14473",
                        "description": "The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14562",
                        "description": "The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The therapeutic efficacy of Calcium cation can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB14738",
                        "description": "The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of hemorrhage can be increased when Citalopram is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of hemorrhage can be increased when Paroxetine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hemorrhage can be increased when Nefazodone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of hemorrhage can be increased when Zimelidine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of hemorrhage can be increased when Seproxetine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of hemorrhage can be increased when Indalpine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of hemorrhage can be increased when Ritanserin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of hemorrhage can be increased when Alaproclate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of hemorrhage can be increased when Duloxetine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of hemorrhage can be increased when Sibutramine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of hemorrhage can be increased when Milnacipran is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the antiplatelet activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Bivalirudin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Dicoumarol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Argatroban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Ardeparin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Phenindione is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Fondaparinux is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Warfarin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Phenprocoumon is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Edetic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Heparin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Enoxaparin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Acenocoumarol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Ximelagatran is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Ancrod is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Sulodexide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Idraparinux is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Otamixaban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Danaparoid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Dalteparin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Ferulic acid is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Nadroparin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Dextran is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Desirudin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11268",
                        "description": "The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Antithrombin III human is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Letaxaban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Darexaban is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Gabexate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Troxerutin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Fluindione is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Reviparin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hemorrhage can be increased when Protein S human is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Rituximab"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Ibritumomab tiuxetan"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Carmustine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Dexrazoxane"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Pemetrexed"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefotiam"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefmenoxime"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefmetazole"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefpiramide"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftazidime"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Loracarbef"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefalotin"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefotaxime"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefdinir"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cephalexin"
                    },
                    {
                        "drugbank-id": "DB00671",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefixime"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cephaloglycin"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefaclor"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceforanide"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefditoren"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefuroxime"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefapirin"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefadroxil"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefprozil"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftriaxone"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefamandole"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefazolin"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefonicid"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefoperazone"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefotetan"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefoxitin"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftizoxime"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefradine"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefepime"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefacetrile"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftibuten"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefpodoxime"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Latamoxef"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftobiprole"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftaroline fosamil"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefaloridine"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftolozane"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefminox"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefroxadine"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Flomoxef"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefatrizine"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefcapene"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefodizime"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefsulodin"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefetamet"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefbuperazone"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefozopran"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefpirome"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefazedone"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftezole"
                    },
                    {
                        "drugbank-id": "DB14725",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefamandole nafate"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The risk or severity of bleeding can be increased when Doxycycline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of adverse effects can be increased when Azithromycin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB09539",
                        "description": "The risk or severity of bleeding can be increased when Omega 3 acid ethyl esters is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may increase the anticoagulant activities of Protein S human"
                    },
                    {
                        "drugbank-id": "DB01606",
                        "description": "The risk or severity of bleeding can be increased when Tazobactam is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of bleeding can be increased when Trazodone is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of bleeding can be increased when Escitalopram is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of bleeding can be increased when Sertraline is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Protein S human can be decreased when used in combination with Cyclopenthiazide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}